As evidence that BLT is in the process of reviewing its options for listing in the US Peter French has said recently, http://www.benitec.com/documents/news/2015/150127_Mergermarket.pdf
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling